PURE BIOSCIENCE, INC. Quarterly Common Stock, Shares Authorized from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Pure Bioscience, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2011 to Q2 2024.
  • Pure Bioscience, Inc. Common Stock, Shares Authorized for the quarter ending July 31, 2024 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 200M 0 0% Jul 31, 2024 10-K 2024-10-29
Q1 2024 150M 0 0% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 150M 0 0% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 150M 0 0% Oct 31, 2023 10-Q 2023-12-14
Q2 2023 200M +50M +33.3% Jul 31, 2023 10-K 2024-10-29
Q1 2023 150M 0 0% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 150M 0 0% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 150M 0 0% Oct 31, 2022 10-Q 2022-12-14
Q2 2022 150M 0 0% Jul 31, 2022 10-K 2023-10-30
Q1 2022 150M 0 0% Apr 30, 2022 10-Q 2022-06-14
Q4 2021 150M 0 0% Jan 31, 2022 10-Q 2022-03-15
Q3 2021 150M +50M +50% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 150M 0 0% Jul 31, 2021 10-K 2022-10-28
Q1 2021 150M +50M +50% Apr 30, 2021 10-Q 2021-06-15
Q4 2020 150M +50M +50% Jan 31, 2021 10-Q 2021-06-15
Q3 2020 100M 0 0% Oct 31, 2020 10-Q 2020-12-15
Q2 2020 150M +50M +50% Jul 31, 2020 10-K 2021-10-28
Q1 2020 100M 0 0% Apr 30, 2020 10-Q 2020-06-11
Q4 2019 100M 0 0% Jan 31, 2020 10-Q 2020-03-12
Q3 2019 100M 0 0% Oct 31, 2019 10-Q 2019-12-13
Q2 2019 100M 0 0% Jul 31, 2019 10-K 2020-10-08
Q1 2019 100M 0 0% Apr 30, 2019 10-Q 2019-06-13
Q4 2018 100M 0 0% Jan 31, 2019 10-Q 2019-03-06
Q3 2018 100M 0 0% Oct 31, 2018 10-Q 2018-12-13
Q2 2018 100M 0 0% Jul 31, 2018 10-K 2019-10-30
Q1 2018 100M 0 0% Apr 30, 2018 10-Q 2018-06-13
Q4 2017 100M 0 0% Jan 31, 2018 10-Q 2018-03-14
Q3 2017 100M 0 0% Oct 31, 2017 10-Q 2017-12-14
Q2 2017 100M 0 0% Jul 31, 2017 10-K 2018-10-25
Q1 2017 100M 0 0% Apr 30, 2017 10-Q 2017-06-08
Q4 2016 100M 0 0% Jan 31, 2017 10-Q 2017-03-02
Q3 2016 100M 0 0% Oct 31, 2016 10-Q 2016-12-14
Q2 2016 100M 0 0% Jul 31, 2016 10-K 2017-10-26
Q1 2016 100M 0 0% Apr 30, 2016 10-Q 2016-06-09
Q4 2015 100M 0 0% Jan 31, 2016 10-Q 2016-03-09
Q3 2015 100M +79.7M +394% Oct 31, 2015 10-Q 2015-12-10
Q2 2015 100M 0 0% Jul 31, 2015 10-K 2016-10-27
Q1 2015 100M 0 0% Apr 30, 2015 10-Q 2015-06-11
Q4 2014 100M 0 0% Jan 31, 2015 10-Q 2015-03-04
Q3 2014 20.3M -79.7M -79.7% Oct 31, 2014 10-K 2015-10-28
Q2 2014 100M 0 0% Jul 31, 2014 10-K 2015-10-28
Q1 2014 100M 0 0% Apr 30, 2014 10-Q 2014-06-10
Q4 2013 100M 0 0% Jan 31, 2014 10-Q 2014-03-13
Q3 2013 100M 0 0% Oct 31, 2013 10-Q 2013-12-12
Q2 2013 100M 0 0% Jul 31, 2013 10-K 2014-10-28
Q1 2013 100M 0 0% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 100M 0 0% Jan 31, 2013 10-Q 2013-02-25
Q3 2012 100M 0 0% Oct 31, 2012 10-Q 2012-12-11
Q2 2012 100M 0 0% Jul 31, 2012 10-K 2013-10-24
Q1 2012 100M +50M +100% Apr 30, 2012 10-Q 2012-06-13
Q4 2011 100M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 100M Oct 31, 2011 10-Q/A 2011-12-22
Q2 2011 100M Jul 31, 2011 10-Q 2012-03-16
Q1 2011 50M Mar 23, 2011 10-K 2012-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.